Literature DB >> 12777694

Renal gene transfer: nonviral approaches.

Yeong-Hau H Lien1, Li-Wen Lai.   

Abstract

Gene therapy has the potential to become an important modality for treating both hereditary and acquired renal diseases. Since renal diseases may involve different cell types in the kidney, it is critical to achieve efficient gene transfer specifically to each cell type. We reviewed the literature on nonviral gene transfer techniques, which are designed to target the kidney specifically. A variety of approaches have been developed to target glomeruli, tubules, renal vasculature, and interstitium with different degree of success. Besides using delivery systems based on liposomes, polycations, and viral fusion proteins, investigators have adopted newer approaches including electroporation and hydrodynamic-based gene transfer, and demonstrated that they are efficient and safe in animal models. Potential clinical applications and safety concerns of gene therapy for renal diseases are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777694     DOI: 10.1385/MB:24:3:283

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.860


  50 in total

1.  Kidney-targeted liposome-mediated gene transfer in mice.

Authors:  L W Lai; G W Moeckel; Y H Lien
Journal:  Gene Ther       Date:  1997-05       Impact factor: 5.250

2.  Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody.

Authors:  J Szebeni; J L Fontana; N M Wassef; P D Mongan; D S Morse; D E Dobbins; G L Stahl; R Bünger; C R Alving
Journal:  Circulation       Date:  1999-05-04       Impact factor: 29.690

Review 3.  Gene transfer in the kidney.

Authors:  V R Kelley; V P Sukhatme
Journal:  Am J Physiol       Date:  1999-01

4.  Distribution of the cellular uptake of phosphorothioate oligodeoxynucleotides in the rat kidney in vivo.

Authors:  M A Carome; Y H Kang; E M Bohen; D E Nicholson; F E Carr; L C Kiandoli; S E Brummel; C M Yuan
Journal:  Nephron       Date:  1997       Impact factor: 2.847

Review 5.  Homologous recombination based gene therapy.

Authors:  L W Lai; Y H Lien
Journal:  Exp Nephrol       Date:  1999 Jan-Feb

6.  The HVJ liposome method.

Authors:  Y Isaka; Y Akagi; Y Kaneda; E Imai
Journal:  Exp Nephrol       Date:  1998 Mar-Apr

Review 7.  Liposome-mediated gene transfer into the tubules.

Authors:  Y H Lien; L W Lai
Journal:  Exp Nephrol       Date:  1997 Mar-Apr

8.  In vivo suppression of the renal Na+/Pi cotransporter by antisense oligonucleotides.

Authors:  R Oberbauer; G F Schreiner; J Biber; H Murer; T W Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 9.  Molecular therapy for renal diseases.

Authors:  M S Lipkowitz; M E Klotman; L A Bruggeman; P Nicklin; B Hanss; J Rappaport; P E Klotman
Journal:  Am J Kidney Dis       Date:  1996-10       Impact factor: 8.860

10.  In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery.

Authors:  G A Brazeau; S Attia; S Poxon; J A Hughes
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

View more
  2 in total

Review 1.  A realistic chance for gene therapy in the near future.

Authors:  Stefan Worgall
Journal:  Pediatr Nephrol       Date:  2004-11-10       Impact factor: 3.714

2.  A method to facilitate and monitor expression of exogenous genes in the rat kidney using plasmid and viral vectors.

Authors:  Peter R Corridon; George J Rhodes; Ellen C Leonard; David P Basile; Vincent H Gattone; Robert L Bacallao; Simon J Atkinson
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.